MINNEAPOLIS, MN — January 10, 2025 (PR Newswire) Saluda Medical, Inc., a commercial-stage medical device company focused on development treatments for chronic neurological conditions using a novel closed-loop, dose-control neuromodulation platform, today announced the closing of a $100 million financing. FLG Managing Partner Laureen DeBuono assisted as Board of Directors…Read More
“Trinitas Partners contacted FLG several years ago as we were rapidly expanding our funds and investment portfolio. We were looking for assistance in build our long-term strategic plans, as well as perform an assessment of our finance team so that we would be able to handle our anticipated growth and effectively manage our funds and the investment properties. Our FLG partner helped us to achieve this and help develop our finance team over the past several years. We would strongly recommend FLG to any firm looking for experienced financial guidance and leadership to help in a period of rapid growth.”
Bill Hooper, Principal, Trinitas Partners LLC Read More